N-acylsphingosine amidohydrolase 1
| UniProt | Protein Name |
|---|---|
| Q13510 |
|
| A0A1B0GUE3 |
|
| A8K0B6 |
|
| Q53H01 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| fatty acid metabolic process |
|
|
| sphingolipid metabolic process |
|
|
| keratinocyte differentiation |
|
|
| negative regulation of DNA-templated transcription |
|
|
| negative regulation of transcription, DNA-templated |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| transcription corepressor activity |
|
|
| protein binding |
|
|
| hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
|
|
| nuclear receptor binding |
|
|
| N-acylsphingosine amidohydrolase activity |
|
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111527 | spinal muscular atrophy with progressive myoclonic epilepsy | |
| DOID:0050464 | Farber lipogranulomatosis | |
| DOID:1927 | sphingolipidosis |
| HPO ID | HPO Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000502 | Abnormal conjunctiva morphology |
| HP:0000608 | Macular degeneration |
| HP:0000639 | Nystagmus |
| HP:0000707 | Abnormality of the nervous system |
| HP:0000708 | Atypical behavior |
| HP:0000726 | Dementia |
| HP:0000737 | Irritability |
| HP:0000766 | Abnormal sternum morphology |
| Disease ID | Disease Name |
|---|---|
| OMIM:159950 |
|
| ORPHA:2590 |
|
| ORPHA:333 |
|
| OMIM:228000 |
|
| Species | Gene ID | Alliance of Genome Resources |
|---|---|---|
| 11886 | MGI:1277124 | |
| 84431 | RGD:621568 | |
| 185021 | WB:WBGene00009192 | |
| 173120 | WB:WBGene00010769 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026